ASIP Members Access  |  Become a Supporter  |  RSS Latest ASIP News  |  SiteMap  |  Job Seekers/Employers  | Facebook Google+ Twitter LinkedIn Contact ASIP

ASIP Companion Meeting at USCAP-
Past Meetings

2013 ASIP Companion Meeting
Interactive Molecular Pathology

Sunday, March 3, 2013, 1:30 PM - 5:00 PM, Baltimore, MD

Download Presentation Materials pdf

Moderators:
Dani S. Zander, MD, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA
Karen L. Kaul, MD, PhD, NorthShore University HealthSystem/University of Chicago, Evanston, IL

  • Bladder Cancer
    Kevin C. Halling, MD, PhD, Mayo Clinic, Rochester, MN  

  • Colon Cancer 
    Antonia R. Sepulveda, MD, PhD, Columbia University, New York, NY  

  • Gliomas
    Arie Perry, MD, University of California, San Francisco, San Francisco, CA  

  • Infectious Disease
    Randall J. Olsen, MD, PhD, The Methodist Hospital, Houston, TX  

  • Hematopathology
    Yue Lynn Wang, PhD, MD, Weill Cornell Medical College, New York, NY

  • Lung Cancer
    Neal Linderman, MD, Brigham and Women's Hospital, Boston, MA  

  • Head & Neck Cancer
    Jennifer L. Hunt, MD and Jennifer Laudadio, MD, University of Arkansas for Medical Sciences, Little Rock, AR

2012 Joint Companion Meeting of ASIP, AMP, and ASCP
Sunday, March 18, 2012 1:30PM - 5:00PM and 7:30PM - 9:30PM
For the first time the American Society for Investigative Pathology (ASIP), the Association for Molecular Pathology (AMP), and the American Society for Clinical Pathology (ASCP) held a jointly programmed Companion Meeting at the USCAP Annual Meeting.

  • Genomic Pathology in Clinical Diagnostics: Promises and Pitfalls of New Technologies
    Moderators:
    Mark E. Sobel, American Society for Investigative Pathology, Bethesda, MD
    George J. Netto, Johns Hopkins Medical Institutions, Baltimore, MD and
    Karen L. Kaul, NorthShore University Health System, Evanston, IL


  • Introduction to the Joint ASIP/AMP/ASCP Companion Meetings on Genomic Pathology
    Mark E. Sobel, American Society for Investigative Pathology, Bethesda, MD

  • Keeping Up With the Next Generation: Perspectives on Massively Parallel Sequencing and Other New Technologies in Clinical Diagnostics
    Wayne W. Grody, UCLA School of Medicine, Los Angeles, CA

  • Surgical Pathologists and the Interpretation of Genomic Information in the New Era of Genomic Medicine
    Karen L. Kaul, NorthShore University Health System, Evanston, IL

  • Laying the Groundwork for Personalized Genomic Studies
    Madhuri R. Hegde, Emory University School of Medicine, Atlanta, GA

  • Why Shouldn't Clinical Microbiologists Have Some Wholesome Whole-Genome Sequencing Fun?
    James M. Musser, The Methodist Hospital Research Institute, Houston, TX

  • Pancreas Pathology in the Era of Whole Genome Sequencing
    Ralph Hruban, Johns Hopkins Medical Institutions, Baltimore, MD

  • Introduction to the Joint AMP/ASCP/ASIP Companion Meetings on Genomic Pathology
    George J. Netto, MD, Johns Hopkins Medical Institutions, Baltimore, MD

  • Clinical Information Systems to Support Personalized Medicine at the Bedside
    Mia Levy, MD, PhD, Vanderbilt University School of Medicine, Nashville, TN

  • Training Residents in Molecular Pathology: Draft AMP Curriculum
    Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA

  • Training Residents in Genomics: The Stanford Approach
    Iris Schrijver, MD, Stanford University Medical Center, Stanford, CA

  • Training Residents in Genomics: The Beth Israel Deaconess Approach
    Richard Haspel, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA

  • Promises and Pitfalls of Genomic Information Technologies: Panel Discussion
    Wayne W. Grody, MD, PhD, UCLA School of Medicine, Los Angeles, CA
    Richard Haspel, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA
    E. Blair Holladay, PhD, SCT(ASCP)CM, ASCP, Chicago, IL
    Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL
    George J. Netto, MD, Johns Hopkins Medical Institutions, Baltimore, MD
    Iris Schrijver, MD, Stanford University Medical Center, Stanford, CA
    Mark E. Sobel, MD, PhD, ASIP, Bethesda, MD

2011 ASIP Companion Meeting
Sunday, February 27, 2011, 1:30PM - 5:00PM
Do Molecular Techniques Always Help the Surgical Pathologist?
Moderators: Maria J. Merino, MD, National Cancer Institute, Bethesda, MD
Christopher Moskaluk, MD PhD, University of Virginia Health Systems, Charlottesville,
V
A

  • How the Surgical Pathologists Helps in Developing New Therapies
    Christopher Moskaluk, MD PhD, University of Virginia Health Systems, Charlottesville, VA

  • Molecular classification in salivary gland tumors. Does it aid in diagnosis?
    Jennifer Hunt, MD, Massachusetts General Hospital

  • Use of Molecular Testing in Thyroid Nodules; The Good, The Bad and The Ugly
    Virginia A. LiVolsi, MD, University of Pennsylvania School of Medicine, Philadelphia, PA

  • The New Molecular Classifications of Breast. Is it Ready for Use in Daily Practice?
    Jose Palacios, Hospital Universitario Virgen del Rocio

  • Morphology is the Molecular Marker in the Recognition of New Tumors in Renal Pathology
    Maria J. Merino, MD, National Cancer Institute, Bethesda, MD

2010 ASIP Companion Meeting
Sunday, March 21, 2010, 1:30PM - 5:00PM
Molecular Markers for Diagnosis and Prognosis: What and When
Moderators: Maria J. Merino, MD, National Cancer Institute, Bethesda, MD, Celina G. Kleer, MD, University of Michigan, Ann Arbor, MI

  • Helpful Markers in the Diagnosis of Prostate Cancer
    Jonathan Epstein, MD, The Johns Hopkins Hospital, Baltimore, MD

  • Breast Cancer, the New and the Old
    Allan Gown, MD, PhenoPath Laboratories, Seattle, WA

  • Mesothelioma Versus Carcinoma: Tempest in a Pleural Teapot?
    Jeffrey Myers, University of Michigan, Ann Arbor, MI

  • Intraductal Pancreatic Tumors
    David Klimstra, MD, Memorial Sloan-Kettering Cancer Center, New York, NY

2009 ASIP Companion Meeting
Sunday, March 8, 2009 1:30PM
Molecular Pathology for the Practicing Pathologist
Moderators: Maria J. Merino, National Cancer Institute, Bethesda, MD
Julian Sanz-Ortega, Hospital Clinico San Carlos, Madrid, Spain

  • The future of the pap smear screening in the era of molecular diagnostics and vaccines
    Mark H. Stoler, University of Virginia Health System

  • Recent advances in the molecular pathology of lung cancer: role of EGFR and KRAS mutation testing in treatment selection
    Marc Ladanyi, Memorial Sloan-Kettering Cancer Center, New York, NY

  • The role of miRNAs in cancer diagnosis and prognosis: no small matter
    Marina Nikiforova, University of Pittsburgh, Pittsburgh, PA

  • Integrating morphology and molecular pathology to manage the diagnosis and treatment of colon cancer
    Julian Sanz-Ortega, Hospital Clinico San Carlos, Madrid, Spain

2008 ASIP Companion Meeting
Sunday, March 2, 2008, 1:30PM
Recent Advances in Molecular Oncology for the Surgical Pathologist
Moderators: Kathleen R. Cho, University of Michigan, Ann Arbor, MI, and Lora Hedrick Ellenson, Weil Medical College of Cornell University, New York, NY

  • The Role of Chromosomal Translocations in the Molecular Pathology of Sarcomas
    Frederic G. Barr, University of Pennsylvania School of Medicine, Philadelphia, PA

  • Molecular Insights Into the Morphological Heterogeneity of Ovarian Carcinomas: Does Histological Type Matter?
    Kathleen R. Cho, University of Michigan, Ann Arbor, MI

  • The Molecular Genetics of Endometrial Carcinoma: What's in it for the Surgical Pathologist?
    Lora Hedrick Ellenson, Weil Medical College of Cornell University, New York, NY

  • Molecular Characterization of Neoplasms in the Pancreas
    Ralph Hruban, Johns Hopkins Medical Institutions, Baltimore, MD

2007 ASIP Companion Meeting
Sunday,March 25, 2007, 1:30PM
Molecular Profiling in Neoplasia for the Surgical Pathologist
Moderator: Thomas J. Giordano, University of Michigan, Ann Arbor, MI

  • TMPRSS2: ERG Gene Fusion Provide Insight Into the Heterogeneity of Prostate Cancer
    Mark A. Rubin, Brigham & Women's Hospital, Boston, MA

  • Using Sarcoma Gene Expression Profiles to Study Cancer Stroma
    Matt van de Rijn, Stanford University Medical Center, Stanford, CA

  • Translating Mass Spectrometry-Based Proteomics of Malignant Lymphoma into Clinical Application
    Megan S. Lim, University of Michigan, Ann Arbor, MI

  • Molecular Profiles of Well-Differentiated Follicular Cell Thyroid Carcinoma
    Thomas J. Giordano, University of Michigan, Ann Arbor, MI

2006 ASIP Companion Meeting
Sunday, February 12, 2006, 1:30PM
Strategies for Negotiating the Diagnostic Gray Zone: Morphologic and Molecular Pathology of Borderline Cases
Organizers: Dani S. Zander, University of Texas Medical School, Houston, TX and Philip T. Cagle, The Methodist Hospital, Houston, TX

  • Atypical Adenomatous Hyperplasia: a Putative Forerunner of Adenocarcinoma of the Lung
    Armando Fraire, University of Massachusetts Medical School, Worcester, MA

  • Liver Tumor Gray Zones: How Do We Shine Some Light in There?
    Neil Theise, Beth Israel Medical Center, New York, NY

  • Molecular Diagnostics in GI Neoplasia
    Stanley Hamilton, University of Texas - MD Anderson Cancer Center, Houston, TX

  • Breast Lesions with Borderline Morphologic Features
    Aysegul Sahin, University of Texas - MD Anderson Cancer Center, Houston, TX

  • Molecular Resolution of Endometrial Cancers
    George Mutter, Harvard Medical School/Brigham & Women's Hospital, Boston, MA

  • Lessons from BRCA: The Distal Fallopian Tube is a Source of Surface "Ovarian" Cancer
    Christopher Crum, Harvard Medical School/Brigham & Women's Hospital, Boston, MA

2005 ASIP Companion Meeting
The Molecular Microscope
Organizer: Maria J. Merino, National Cancer Institute, Bethesda, MD

  • Molecular Aspects of Thyroid Neoplasia and Diagnostic Implications
    Juan Rosai, Istituto Nazionale Tumori, Milan, Italy

  • Molecular Aspects of Anaplastic Large Cell Lymphoma
    L. Jeffrey Medeiros, University of Texas MD Anderson Cancer Center, Houston, TX

  • Chromogenic In Situ Hybridization in Diagnosis and Prognosis of Breast and Renal Cancers
    Maria J. Merino, National Cancer Institute, Bethesda, MD

  • Genetic Analysis of Malignant Melanoma: Do We Still Need Histology?
    Victor G. Prieto, University of Texas MD Anderson Cancer Center, Houston, TX